The editorial highlights the underrepresentation of women in the field of science, particularly in nuclear medicine, where they face systemic challenges and biases that hinder their recognition and contributions. Despite constituting only 31% of researchers globally as of 2022, women have played pivotal roles in nuclear medicine and radiation sciences, with historical examples such as Rosalind Franklin and Maria Skłodowska-Curie exemplifying their impact. Recent studies cited in the article discuss advancements in targeted radiopharmaceutical therapies for cancer and the importance of recognizing gender-inclusive terminology in medical nomenclature to foster equality in treatment opportunities. This research aims to celebrate women's contributions in nuclear medicine while advocating for increased gender equity in the field.
Mon, 01 Sep 2025 18:37:42 GMT | Frontiers